n-vinyl-2-pyrrolidinone has been researched along with Central Nervous System Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FRAUSCHER, A | 1 |
Kilymzhanova, BT | 1 |
Clatch, RJ; Dal Canto, MC; Lipton, HL; Metzner, R; Miller, SD | 1 |
3 other study(ies) available for n-vinyl-2-pyrrolidinone and Central Nervous System Disease
Article | Year |
---|---|
[Epidemiological and clinical observations during a viral epidemic of the central nervous system].
Topics: Central Nervous System Diseases; gamma-Globulins; Humans; Povidone | 1954 |
[Selective detoxication of the central nervous system in patients with maxillofacial phlegmons].
Topics: Carotid Artery, Common; Cellulitis; Central Nervous System Diseases; Facial Bones; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Povidone | 2003 |
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).
Topics: Animals; Cell Adhesion; Central Nervous System Diseases; Demyelinating Diseases; Enterovirus; Enterovirus Infections; Flow Cytometry; In Vitro Techniques; Kinetics; Macrophages; Maus Elberfeld virus; Mice; Mice, Inbred Strains; Monocytes; Povidone; Silicon Dioxide; Viral Plaque Assay; Virus Replication | 1990 |